Skip to main content
Premium Trial:

Request an Annual Quote

Base4 Drops Bioinformatics From Name, Expands Reach

Premium

TORONTO--Base4 Bioinfor-matics said it is dropping the word bioinformatics from its name to reflect its significantly expanded strategy, beyond providing bioinformatics services. The company's broader mission includes selling its knowledge-management enterprise software package for pharmaceutical research and development.

Martin Sumner-Smith, Base4's president and CEO, said the company got its start "by offering products and services to manage the flood of biological information coming from gene analysis." Now, he said, the company serves general information needs of pharmaceutical discovery and development. "Base4 is now a general pharmaceutical informatics company."

Base4 claimed that there are nearly 1,000 users of its flagship product PharMatrix.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.